|
|
Am. J. Biomed. Sci. 2012, 4(2), 123-131; doi: 10.5099/aj120200123 |
Pretreatment with A Small-Molecule Tumor Necrosis
Factor-Alpha (TNF-α) Inhibitor, UTL-5g, Reduced Radiation-Induced Acute
Liver Toxicity in Mice |
Jiajiu Shaw1*,
Jie Zhang2, Ming Zhang 2, Frederick Valeriote3,
Ben Chen4 |
121st
Century Therapeutics, Inc., |
2Department
of Radiation Oncology, |
3Department
of Internal Medicine, Henry Ford Health System, |
4Department
of Internal Medicine, Wayne State University School of Medicine, Detroit, MI
48201, USA |
*Corresponding author: |
J. Shaw, Ph.D. |
21st Century
Therapeutics, Inc.. |
|
|
Telephone: 734-330-6052 |
E-mail: jshaw@21-cti.com |
Abstract Radiation-induced
liver toxicity is a major limitation to the use of radiation in the treatment
of intrahepatic cancers. The purpose of this study
was to evaluate the potential radioprotective
effect of a small-molecule tumor necrosis factor alpha (TNF-a) inhibitor,
UTL-5g, against radiation-induced acute liver injury. Mice were pre-treated by i.p. injection with UTL-5g and control
vehicle one hr prior to liver irradiation at 15 Gy.
Blood and liver were collected 2 hr after irradiation and analyzed for levels
of aspartate aminotransferase
(AST) and alanine aminotransferase
(ALT) activities in serum and TNF-α in liver tissue extracts. Both AST and ALT in serum and
TNF-α in liver induced by irradiation were significantly reduced by UTL-5g in a drug dose-dependent
manner. The reductions of AST, ALT and TNF-α appeared to correlate
with the reduction of liver apoptosis detected by terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay. A
radiation dose escalation study (5, 15 and 25 Gy)
showed that UTL-5g at 60 mg/kg was effective as a radioprotective
agent at 5 and 15 Gy; the protection was only modest
at 25 Gy. In summary, our results suggest that the TNF-α inhibitor,
UTL-5g, is potentially radioprotective against acute phase of radiation-induced liver injury. |
Keywords: liver, radiation, radioprotective, TNF-α, UTL-5g. Download the full article (PDF)
|
Publisher | Missions and Scope | Editorial Board | Instructions for Authors |
© American Journal of Biomedical Sciences 2007-2021. All Rights Reserved. |